The epidemiology of amoebiasis.
D000349:Africa; D000562:Amebiasis / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology* / Q000266:history; D001172:Arthritis, Rheumatoid / Q000150:complications; D001208:Asia; D004064:Digestive System / Q000382:microbiology; D004404:Dysentery, Amebic / Q000209:etiology; D004748:Entamoeba histolytica / Q000033:anatomy & histology / Q000302:isolation & purification / Q000472:pathogenicity*; D005060:Europe; D005132:Eye Manifestations; D005260:Female; D006505:Hepatitis / Q000209:etiology; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D007049:Iatrogenic Disease; D008101:Liver Abscess, Amebic / Q000209:etiology; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D009656:North America; D012140:Respiratory Tract Diseases / Q000150:complications; D012698:Serologic Tests; D013020:South America
D008795:Metronidazole